Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fox

Showing results (1251-1260 of 1,511) with videos related to

Pageof 152
Sort By:
Lancet (London, England)|March 25, 2014
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trialJeremy Chataway, Nadine Schuerer, Ali Alsanousi, et al.
AIDS (London, England)|November 24, 1999
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patientJ M Orenstein, M Feinberg, C Yoder, et al.
Brain : a Journal of Neurology|February 28, 2012
Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological featuresColin J Mahoney, Jon Beck, Jonathan D Rohrer, et al.
Journal of Alzheimer'S Disease : JAD|December 12, 2017
The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) TrialPatrick G Kehoe, Peter S Blair, Beth Howden, et al.
Alzheimer'S Research & Therapy|August 17, 2018
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroupIone O C Woollacott, Jennifer M Nicholas, Amanda Heslegrave, et al.
Blood Advances|April 27, 2022
Functional interaction between compound heterozygous TERT mutations causes severe telomere biology disorderAram Niaz, Jia Truong, Annabel Manoleras, et al.
Radiology|August 2, 2022
Point-of-Care Brain MRI: Preliminary Results from a Single-Center Retrospective StudyEdward Kuoy, Justin Glavis-Bloom, Gabrielle Hovis, et al.
Progress in Neurobiology|December 7, 2010
Biomarkers for Alzheimer's disease therapeutic trialsHarald Hampel, Gordon Wilcock, Sandrine Andrieu, et al.
Theranostics|July 21, 2020
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast CancerAlison K Esser, Michael H Ross, Francesca Fontana, et al.
Journal of Alzheimer'S Disease : JAD|February 6, 2013
Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutationsRachael I Scahill, Gerard R Ridgway, Jonathan W Bartlett, et al.
Pageof 152

Showing results (1251-1260 of 1,511) with videos related to

Sort By:
Pageof 152
Lancet (London, England)|March 25, 2014
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trialJeremy Chataway, Nadine Schuerer, Ali Alsanousi, et al.
AIDS (London, England)|November 24, 1999
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patientJ M Orenstein, M Feinberg, C Yoder, et al.
Brain : a Journal of Neurology|February 28, 2012
Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological featuresColin J Mahoney, Jon Beck, Jonathan D Rohrer, et al.
Journal of Alzheimer'S Disease : JAD|December 12, 2017
The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) TrialPatrick G Kehoe, Peter S Blair, Beth Howden, et al.
Alzheimer'S Research & Therapy|August 17, 2018
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroupIone O C Woollacott, Jennifer M Nicholas, Amanda Heslegrave, et al.
Blood Advances|April 27, 2022
Functional interaction between compound heterozygous TERT mutations causes severe telomere biology disorderAram Niaz, Jia Truong, Annabel Manoleras, et al.
Radiology|August 2, 2022
Point-of-Care Brain MRI: Preliminary Results from a Single-Center Retrospective StudyEdward Kuoy, Justin Glavis-Bloom, Gabrielle Hovis, et al.
Progress in Neurobiology|December 7, 2010
Biomarkers for Alzheimer's disease therapeutic trialsHarald Hampel, Gordon Wilcock, Sandrine Andrieu, et al.
Theranostics|July 21, 2020
Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast CancerAlison K Esser, Michael H Ross, Francesca Fontana, et al.
Journal of Alzheimer'S Disease : JAD|February 6, 2013
Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutationsRachael I Scahill, Gerard R Ridgway, Jonathan W Bartlett, et al.
Pageof 152